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osting by EAbstract The insecticide chlorpyrifos (CPF) is widely used in the Kingdom of Saudi Arabia (KSA)
to control agricultural pests. The present work is a preliminary investigation of the effect of CPF on
healing of cutaneous leishmaniasis (CL) lesions, caused by Leishmania major in farmers exposed to
this insecticide, after treatment with Pentostam. Lesion diameters were measured and CPF con-
centrations in the blood plasma of farmer and non-farmer CL patients in Al-Ahsa were detected
by gas chromatography/mass spectrometry/mass spectrometry before and 6 weeks after treatment
with Pentostam. CPF concentrations in the blood of farmer patients ranged between 4.570 and
7.096 ng/ll (mean = 6.19 ± 0.881 ng/ll) before and after treatment with Pentostam. The mean
lesion diameter in these patients decreased by a factor of 2.21 after treatment with Pentostam; they
measured 1.85–11.75 mm, (mean = 6.165 ± 3.500 mm) before treatment and 0.22–6.10 mm
(mean = 2.796 ± 2.102 mm) after treatment. Lesion diameter increased exponentially with the
increase of CPF concentration in the patients’ blood. CPF was not detected in the non-farmer
patients before or after treatment. Their mean lesion diameter decreased by a factor of 6.86 after
treatment with Pentostam; they measured 1.33–7.10 mm (mean = 2.882 ± 1.764 mm) before
treatment and 0.11–0.92 mm (mean = 0.425 ± 0.277 mm) after treatment. The mean lesion diam-
eter in farmer patients was much greater than that of non-farmer patients both before (2.14·) and
after (6.657·) treatment with Pentostam. Chronic exposure to low levels of the pesticide
aggravates the development and delays the healing of CL lesions due to immunotoxicity and/or(M.H. Al-Jaser).
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32 A.N. Al-Dawood et al.peripheral neurotoxicity caused by CPF. Further detailed studies would assess CPF effect on the
severity of infection with CL in agricultural workers continuously exposed to this insecticide in dif-
ferent areas of KSA in conformity of their ﬁnding.
ª 2009 King Saud University. All rights reserved.1. Introduction
Pentostam is considered as an effective treatment for CL
caused by Leishmania major and has been used extensively
for the treatment of this disease in the Kingdom of Saudi Ara-
bia (KSA) (Peters and Al-Zahrani, 1987; Al Tawﬁq and
AbuKhamsin, 2004; Al-Jaser, 2005). Al-Jaser (1995) observed
some patients do not respond properly to treatment and attrib-
uted this unresponsiveness due to exposure of patients to
chemical pollutants such as pesticides (Breckenridge et al.,
1987). Chlorpyrifos (CPF) (O,O0-diethyl 3,5,6-trichloro-2-
pyridinyl-phosphorothioate), a broad-spectrum organo-phos-
phorous (OP) insecticide, has been widely used in KSA for
the control of agricultural pests. OP compounds are highly
toxic to vertebrates (Sultatos and Murphy, 1983; Spies et al.,
1988; Kousba et al., 2004; Zhao et al., 2006), and CPF is par-
ticularly considered to be neurotoxic (Albers et al., 2004), car-
diotoxic, hepatotoxic (Meyer et al., 2004) and immunotoxic
(Galloway and Handy, 2003).
Lately, we observed that the development of CL lesions in
BALB/cmice infectedwithL.majorwas aggravatedby exposure
to CPF. The aim of this paper is to investigate the effect of
chronic exposureof humans toCPFon thehealing ofCL lesions.2. Materials and methods
2.1. Patients’ treatment
Forty-three farmer and non-farmer CL patients attending the
Dermatology Clinic at Al-Ahsa Clinical Center in KSA were
the subject of this study. However, only 16 farmers and 15
non-farmers reported after treatment. After obtaining an in-
formed consent from all patients, they were examined for skin
lesions. Lesions, mainly on the forearms and lower parts of
the legs of these patients, were clinically diagnosed and con-Figure 1 Chlorpyrifﬁrmed to be caused by L. major by the polymerase chain reac-
tion (unpublished data). Each patient was given a single course
of daily intramuscular injections of 600 mg Pentostam (penta-
valent antimony sodium stibogluconate, the Wellcome Foun-
dation Ltd., Berkhamstead, England) for 21 days. The lesion
diameters were measured using a micrometer (Pocotest dial
caliper gauge, Carbonze, UK) and blood samples were collected
from the patients in vacutainer tubes (Becton Dickenson, USA)
containing disodium ethane diamine tetraacetic acid dihydrate
(EDTA) (10 mg/ml) from Serva Feinbiochemica (Heidelberg,
Germany) before and 6 weeks after treatment with Pentostam.
2.2. GC/MS/MS
CPF analysis was performed as described by Tarbah et al.
(2001) using a Hewlett Packard GC/MS/MS system: GC 5890
MSD 5970 equipped with a Hewlett Packard automatic liquid
sampler HP 7673. Column was HP 5 MS, 30 m length, i.d.
0.25 mm (0.25 lm ﬁlm thickness), carrier gas was helium (pres-
sure 70 kPa) and split/purge off time was 2 min. The injector
temperature was 270 C, transfer line temperature was
280 C, temperature program included an initial temperature
60 C for 2 min, 40 C/min to 90 C, 15 C/min to 300 C and
maintained for 3 min (total run time: 20 min). The mass spec-
trometer was in the electron impact mode at 70 eV scanning
from m/z 50–450 mass units. Fig. 1 shows the CPF chromato-
gram obtained (Retention time, tR = 13.133 min). A standard
curve was formed by measuring serial 4-fold dilutions (2, 4, 6
and 8 · 105 mg/ml) of CPF (94.5% purity purchased from
Avonchem, UK) using GC/MS/MS analysis described above.
2.3. Preparation of blood plasma samples and CPF extraction
procedure
In Eppendorf tubes, aliquots each of 0.7 ml plasma sample were
vortexed with 1 ml toluene for 2 min and then centrifuged atos chromatogram.
Table 1 Results of GC/MS/MSa assay for chlorpyrifos concentration in the blood plasma of farmer patients and their lesion
diameters before and 6 weeks after treatment with Pentostam.
Patients’ no. CPF concentration before and 6 weeks after
treatment (ng/ll)
Lesion diameter before and 6 weeks after
treatment (mm)
Before After Before After
1 6.116 6.116 3.95 0.91
2 7.096 7.096 14.75 3.60
3 6.043 6.043 3.85 1.22
4 6.043 6.043 3.55 2.11
5 6.956 6.956 7.65 4.80
6 6.546 6.546 7.05 5.10
7 4.570 4.570 1.85 0.50
8 6.421 6.421 4.65 2.33
9 7.096 7.096 11.75 6.10
10 6.721 6.721 7.10 3.11
11 4.570 4.570 2.10 1.10
12 6.974 6.974 9.10 2.32
13 4.570 4.570 2.60 0.22
14 5.610 5.610 3.50 0.99
15 6.721 6.721 7.35 4.10
16 6.956 6.956 7.85 3.22
Mean ± SD 6.188 ± 0.881 6.188 ± 0.881 6.165 ± 3.500 2.796 ± 2.102
a Gas chromatography/mass spectrometry/mass spectrometry.
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amount of 1 ll of the supernatant was analyzed directly for the
presence CPF by GC/MS/MS as described above (Tarbah
et al., 2001).2.4. Statistical analysis
The means and standard deviations (SD) of the data were ob-
tained using GraphPad Prizm software version 3.0 and were
compared using paired Students’ t-test.Table 2 Lesion diameters in non-farmer patients before and 6 wee
Patients’ no. Lesion dia
Before
1 1.86
2 2.20
3 3.10
4 1.55
5 4.65
6 2.70
7 2.00
8 3.40
9 6.11
10 7.10
11 1.78
12 2.22
13 1.13
14 1.05
15 1.33
Mean ± SD 2.882 ± 1
a No chlorpyrifos was detected in the blood of these patients.3. Results
3.1. Lesion diameter before and 6 weeks after treatment
The mean lesion diameter in farmer patients before treatment
(range 1.85–11.75 mm, mean 6.165 ± 3.500 mm) was 2.21·
larger (P< 0.0001) than that after treatment (range 0.22–
6.10 mm, mean 2.796 ± 2.102 mm) (Table 1). In non-farmer
patients, the mean lesion diameter before treatment (range
1.33–7.10 mm, mean 2.882 ± 1.764 mm) was 6.86· larger
(P< 0001) than that after treatment (range 11–0.92 mm,ks after treatment with Pentostam.a
meter before and 6 weeks after treatment (mm)
After
0.41
0.11
0.12
0.44
0.21
0.71
0.11
0.84
0.92
0.61
0.22
0.55
0.15
0.75
0.22
.764 0.425 ± 0.277
34 A.N. Al-Dawood et al.mean 0.425 ± 0.277 mm) (Table 2). The mean lesion diameter
of farmer patients was 2.14· larger (P< 0.0005) than that of
non-farmer patients before treatment and 6.657· after
treatment.
3.2. CPF concentration in patients’ plasma before and 6 weeks
after treatment
The GC/MS/MS analysis to detect CPF concentration in the
plasma samples of farmer patients showed that the CPF level
was the same before and 6 weeks after treatment and ranged
between 4.570 and 7.096 ng/ll (mean 6.188 ± 0.881 ng/ll)
(Table 1). On the other hand, no CPF was detected by this as-
say in the plasma of non-farmer patients before or after
treatment.
3.3. Relation between lesion diameter and CPF concentration
When the CPF concentrations in the farmer patients’ plasma
were plotted against their lesion diameters (Figs. 2 and 3), a0
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Figure 2 Relationship between lesion diameters and chloropyriﬁos
Pentostam.
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Figure 3 Relationship between lesion diameters and chlorpyrifos con
Pentostam.signiﬁcant positive correlation was observed before
(r= 0.819) and after (r= 0.675) treatment; lesion diameter in-
creased exponentially with the increase in the CPF concentra-
tion (in ng/ll) both before and after treatment with
Pentostam.
4. Discussion
CL is a common health problem among agricultural workers
in KSA (Al-Gindan et al., 1984; Peters and Al-Zahrani,
1987; Peters, 1988; Dye et al., 1989). Although the Saudi Agri-
culture Ministry forbids the use of the highly toxic CPF since
20/4/2004, it is still in use in KSA to control agricultural pests
(http://www.agrwat.gov.sa/public/portal). Thus, farmers are
exposed continuously to this pesticide and therefore, their
blood was found to contain a steady concentration of CPF
during the present study. Although CPF was present in very
low concentrations in their blood, it seems that these quantities
were sufﬁcient to affect their response to treatment with
Pentostam. In support of this assumption were the larger4 5 6 7 8
ncentration (ng/µl)
concentrations in farmer patients’ plasma before treatment with
4 5 6 7 8
centration (ng/µl)
centrations in farmer patients’ plasma 6 weeks after treatment with
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healing of the farmers’ CL lesions when compared to those
of the non-farmer workers, and the exponential increase in
lesion diameter with the increase in CPF concentration in the
farmers’ blood.
In a previous study, treatment with CPF for 2 weeks was
found to aggravate CL lesion development in BALB/c mice
(Al-Dawood et al., 2008). Such aggravation has probably oc-
curred in the infected farmers and might be attributed to alter-
ation of the their immune system since CPF has been reported
to be immunotoxic (Galloway and Handy, 2003); alteration of
the immune system was reported to interfere with treatment of
CL in AID’s patients (Altes et al., 1991; Gradoni and Gramic-
cia, 1994). CPF also affected neurotransmission by acetylcho-
line esterase (AChE) in animals and humans (reviewed by
Zhao et al., 2006). Sufﬁcient inhibition of AChE by CPF
caused excessive accumulation of acetylcholine, which in turn
might cause a neurotoxic effect on the peripheral nerves sup-
plying the cutaneous area of the lesion and might have contrib-
uted to the aggravation of the lesions.Acknowledgements
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